CGTUpscaling AAV gene therapyLatest News Biovian Oy’s second generation AAV platform will include Remedium Bio Inc.’s lead treatment candidate against Osteoarthritis. Read more 22 March 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/160.jpg 1280 1920 Margarita Milidakis /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Margarita Milidakis2023-03-22 11:10:162024-07-12 12:26:51Upscaling AAV gene therapy